Medpace, A Top 1% Earnings Stock, Just Crushed Expectations
easily beat Wall Street's first-quarter projections and boosted its full-year outlook, and MEDP stock rocketed early Tuesday. X Medpace is a contract research organization, or CRO. It helps companies run the clinical studies they need to gain approval of new drugs and medical devices. During the…#medp #xmedpace #cro #medpace #marketsmithcom #epsrating #compositerating #ibddigital #allisongatlin #ibdagatlin
Source: Reuters: Health - Category: Consumer Health News Source Type: news